Five9, Inc. FIVN 深 沪
交易中 02-06 10:03:44 美东时间
16.485
+0.475
+2.97%
华盛通- 最 高16.73
- 今 开16.20
- 成交量 14.01万股
- 最 低 16.16
- 昨 收 16.01
- 总市值 12.89亿
- 52周最高 49.90
- 市盈率 静 --
- 换手率 0.18%
- 52周最低 15.705
- 委 比 -33.33%
- 总股本 7821.61万
- 历史最高 211.68
- 量 比 1.07
- 振 幅 3.56%
- 历史最低 3.48
- 每 手 1
- 风险率 5.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Five9 Names Amit Mathradas CEO Effective Feb. 2, 2026; Approves Transition Agreement For Outgoing CEO Michael Burkland
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.Amended and Restated Employment Transition Agreement In connection
01-21 21:40
美股大行评级 | 阿斯麦、美光科技、SanDisk获大行上调目标价；美国银行、富国银行绩后遭多家机构下调目标价
今日重点评级关注：Benchmark：维持TNL Mediagene"投机性买入"评级，目标价从3.5美元升至14美元；康托·菲茨杰拉德：维持Eupraxia Pharmaceuticals"超配"评级，目标价从11美元升至19美元
01-16 10:04
Five9 Rolls Out Enterprise AI Customer Experience Solution With Google Cloud
Five9, Inc. partners with Google Cloud to deliver AI-powered customer experiences, offering unified platform for agents and admins.
01-13 18:52
Stock Market Today: S&P 500, Dow Jones Futures Slip Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus
U.S. stock futures declined on Tuesday after a positive close on Monday. Futures of major benchmark indices were trading lower.
01-13 18:28
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Barclays Maintains Overweight on Five9, Lowers Price Target to $25
Barclays analyst Raimo Lenschow maintains Five9 (NASDAQ:FIVN) with a Overweight and lowers the price target from $29 to $25.
01-13 04:01
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Piper Sandler Downgrades Five9 to Neutral, Lowers Price Target to $21
Piper Sandler analyst James Fish downgrades Five9 (NASDAQ:FIVN) from Overweight to Neutral and lowers the price target from $26 to $21.
01-06 00:09
Five9 in focus as Piper Sandler downgrades, cuts price target
Five9 (FIVN) was in focus on Monday as Piper Sandler downgraded the cybersecurity company and cut its price target on the stock. Shares fell fractionally in premarket trading. “While shares look compe...
01-05 21:24
Five9 appoints Amit Mathradas as next CEO
Five9 (FIVN) on Wednesday appointed Amit Mathradas as the CEO and Director, effective February 2, 2026. Mike Burkland, current board chairman, is to retire from the CEO position in July, and Mathrada...
2025-12-17 23:59
